-
-
-
-
-
-
-
9 Meters Biopharma (NMTR) Announces Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)
-
-
-
-
-
-
-
9 Meters Biopharma Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
9 Meters Biopharma, Inc. to Present at the 23rd Annual BIO CEO & Investor Conference
-
-
-
-
-
-
-
UPDATE: 9 Meters Biopharma (NMTR) Prices 46.154M Share Common Offering at $0.65/Sh
-
-
-
-
-
-
-
9 Meters Biopharma, Inc. Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
-
-
-
-
-
-
-
9 Meters Biopharma, Inc. Provides Business Update and Announces Second Quarter 2020 Results
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

